文献速递血栓与止血

COVID-19诊断后住院与非住院患者血栓并发症发生率

Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis.
PubMed 文献 · Br J Haematol · 2021-05-24

Infection with coronavirus disease-2019 (COVID-19) may predispose for venous thromboembolism (VTE). There is wide variation in reported incidence rates of VTE in COVID-19, ranging from 3% to 85%. Therefore, the true incidence of thrombotic complications in COVID-19 is uncertain.…

要点

  • 实际发生率可能低于既往广泛报告的3%-85%范围。

研究设计与样本

  • 两项正在进行的 prospective cohort studies(前瞻性队列研究),纳入住院和非住院COVID-19患者。

临床怎么用

  • 临床应关注住院COVID-19患者的VTE风险,出院后3个月内仍需警惕。
  • 非住院患者VTE风险较低,可根据个体情况评估预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infection with coronavirus disease-2019 (COVID-19) may predispose for venous thromboembolism (VTE). There is wide variation in reported incidence rates of VTE in COVID-19, ranging from 3% to 85%. Therefore, the true incidence of thrombotic complications in COVID-19 is uncertain. Here we present data on the incidence of VTE in both hospitalised and non-hospitalised patients from two ongoing prospective cohort studies. The incidence of VTE after diagnosis of COVID-19 was 3·9% [95% confidence interval (CI): 2·1-7·2] during hospitalisation, 0·9% (95% CI: 0·2-3·1) in the three months after discharge and 0·2% (95% CI: 0·00-1·25) in non-hospitalised patients, suggesting an incidence rate at the lower end of that in previous reports.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Tholin B, Ghanima W, Einvik G, et al. Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis. Br J Haematol. 2021. PMID: 34028814. doi:10.1111/bjh.17522

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。